FAKTOR-OPTIONSSCHEIN - AMGEN Share Price

DE000MF8NCQ6

Delayed Börse Stuttgart 01:13:50 14/05/2024 am IST
0.195 ^EUR	+2.63%

Current month	-37.10%
1 month	-40.91%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Enabling The "Full Scope" Of Claims In View Of The Supreme Court's Decision In Amgen	13/05	AQ
Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating	13/05	MT
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE	10/05	PR
CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904	09/05	AQ

More news

Quotes 5-day view

Date	Price	Change
13/24/13	0.195	+2.63%
10/24/10	0.19	+2.15%
09/24/09	0.186	-7.46%
08/24/08	0.201	-5.19%
07/24/07	0.212	-1.40%

Delayed Quote Börse Stuttgart

Last update May 14, 2024 at 01:13 am IST

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Morgan Stanley
WKN	MF8NCQ
ISIN	DE000MF8NCQ6
Date issued	30/11/2018
Strike	411.3 $
Maturity	Unlimited
Parity	482.86 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	14.95 €
Lowest since issue	0.167 €

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Consensus: Amgen Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

308.4 USD

Average target price

314.6 USD

Spread / Average Target

+2.01%

Consensus